Reply to: Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine
Cephalalgia · 2026-08 · 46 (8)
DOI: 10.1177/03331024261474833 ↗Kurz gefasst
Leserbrief in der Zeitschrift Cephalalgia, online erschienen am 19.08.2026. Verfasst von Yingqiang Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Ch…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Institute of Integrated Traditional Chinese and Western Medicine, Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Yingqiang Li, Lingling Yu, Dan Bing
Zitieren
APA
Li, Y., Yu, L., & Bing, D. (2026). Reply to: Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine. Cephalalgia, 46(8). https://doi.org/10.1177/03331024261474833
Vancouver
Li Y, Yu L, Bing D. Reply to: Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine. Cephalalgia. 2026;46(8). doi:10.1177/03331024261474833
BibTeX
@article{Li2026,
author = {Li, Yingqiang and Yu, Lingling and Bing, Dan},
title = {Reply to: Baseline severity is not treatment timing in acute rimegepant treatment for vestibular migraine},
journal = {Cephalalgia},
year = {2026},
volume = {46},
number = {8},
doi = {10.1177/03331024261474833}
}
EUVIMED